• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during pregnancy and nursing is challenging for women with the condition. There is a lack of information about how adhd medication works long-term exposure to these medications may affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological conditions like hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to evaluate the benefits of using it versus the risks for the fetus. The doctors don't have the information to provide clear recommendations, but can provide information about risks and benefits to help pregnant women make an informed decision.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy were not at a greater risk of fetal malformations or structural birth defects. The researchers used a large population-based study of case-control to determine the prevalence of major structural birth defects in babies born to mothers who took stimulants during early pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to confirm that the classification was accurate and to eliminate any bias.

The research conducted by the researchers was not without limitations. The researchers were unable, in the first place to differentiate the effects caused by the medication from the disorder. That limitation makes it difficult to know whether the limited associations observed in the exposed groups result from medication use or confounding by comorbidities. Researchers also did not examine long-term outcomes for the offspring.

The study found that infants whose mothers took ADHD medication during pregnancy had a higher chance of being admitted to the neonatal care unit (NICU), compared to those whose mothers didn't take any medication during pregnancy or discontinued taking their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean birth or having a child with a low Apgar score (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the higher benefit to both mother and child from continued treatment for the woman's condition. Physicians should speak with their patients about this and as much as possible, assist them develop coping strategies that can lessen the effects of her disorder on her daily functioning and her relationships.

Interactions with Medication

Many doctors are faced with the decision of whether to continue treatment or stop as more women are diagnosed with ADHD. These decisions are usually made without clear and authoritative evidence. Instead, doctors must consider their own expertise and experience, as well as the experiences of other physicians and the research that has been conducted on the subject.

The issue of possible risks to the infant can be particularly tricky. A lot of studies on this issue are based on observational evidence instead of controlled research and their conclusions are often contradictory. In addition, most studies limit their analysis to live births, which can underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study presented in the journal club addresses these shortcomings by analyzing both data on live and deceased births.

Conclusion A few studies have shown a positive correlation between ADHD medications and certain birth defects, other studies have not shown such a relationship. Most studies have shown that there is a neutral, or somewhat negative, impact. In all cases, a careful study of the risks and benefits must be performed.

It isn't easy, but not impossible for women suffering from ADHD to stop taking their medication. In fact, in a recent article in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness and family conflict for patients with ADHD. A loss of medication may affect the ability to safely drive and perform work-related tasks, which are vital aspects of everyday life for those with ADHD.

She suggests women who are unsure about whether to continue or discontinue medication due to their pregnancy consider the possibility of educating friends, family members, and coworkers on the condition, its impact on daily life, and the benefits of keeping the current treatment plan. It can also help the woman feel supported as she struggles with her decision. Certain medications can pass through the placenta. If a woman decides to stop taking her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her infant.

Birth Defects Risk

As the use and abuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) is increasing the concern over the potential adverse effects of the drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Researchers used two massive data sets to study more than 4.3 million pregnancies and determine if stimulant medication use caused birth defects. Although the risk overall is low, the researchers discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects, like ventriculo-septal defects (VSD).

The authors of the study found no connection between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The results are in line with previous studies showing the presence of a small, but significant increase in the risk of heart malformations among women who started taking ADHD medications before the birth of their child. This risk increased during the latter part of pregnancy, as many women are forced to stop taking their adhd focus medication medication.

Women who used online adhd medication medications in the first trimester of their pregnancy were also more likely to experience caesarean sections, a low Apgar score after delivery and a baby who needed breathing assistance at birth. However the authors of the study were not able to eliminate bias due to selection by restricting the study to women who didn't have any other medical conditions that could have contributed to these findings.

Researchers hope that their study will help doctors when they meet pregnant women. They suggest that although discussing risks and benefits is important however, the decision to stop or maintain medication should be based on the woman's needs and the severity of her adhd medication pregnancy; my review here, symptoms.

The authors also advise that while discontinuing the medications is an option, it is not a recommended practice because of the high prevalence of depression and other mental health problems among women who are pregnant or recently postpartum. Furthermore, research suggests that women who choose to stop taking their medications are more likely to have a difficult time getting used to life without them after the birth of their baby.

Nursing

It can be a stressful experience becoming a mother. Women who suffer from ADHD can face severe challenges when they must manage their symptoms, go to doctor appointments and prepare for the birth of a child and adjust to new routines. Therefore, many women choose to continue taking their ADHD medications throughout pregnancy.

The risk to nursing infant is low because the majority of stimulant medication passes through breast milk at a low level. However, the frequency of exposure to medication by the infant can differ based on dosage, frequency it is administered and the time of day the medication is administered. In addition, various medications are introduced into the baby's system through the gastrointestinal tract, or through breast milk. The effect on the health of a newborn isn't completely comprehended.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the absence of research. It's a difficult choice for the woman who must weigh the advantages of continuing her medication against the risk to the embryo. Until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and if they plan or are taking to take medication during the perinatal time.

Numerous studies have proven that women can continue taking their ADHD medication safely during pregnancy and while breast-feeding. As a result, more and more patients choose to do so, and in consultation with their physician, they have found that the benefits of continuing their current medication far outweigh any potential risks.

It is essential for women with ADHD who are considering breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their doctor, and the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD recognize their symptoms and underlying disorder Learn about the available treatments and to reinforce existing coping strategies. This should be a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, monitoring of signs of deterioration and, if needed, adjustments to the medication regimen.